FDA Inspection
GlaxoSmithKline dba Human Genome Sciences IncGlaxoSmithKline dba Human Genome Sciences Inc – FDA Inspection, Nov 5, 2013
Record Details
This FDA Inspection record concerns GlaxoSmithKline dba Human Genome Sciences Inc, with an inspection on November 5, 2013, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- November 5, 2013
- Product Type
- Drugs
View Company Profile
ID · fcad030a-10f3-4e6a-9baa-048402dcf430
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 854065
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of GlaxoSmithKline dba Human Genome Sciences Inc
8| Date | Classification | Office | Project area |
|---|---|---|---|
| July 31, 2025 | Not classified | Baltimore District Office | |
| December 11, 2023 | Not classified | Baltimore District Office | |
| March 15, 2019 | Not classified | Baltimore District Office | |
| August 30, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 11, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for GlaxoSmithKline dba Human Genome Sciences Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.